Submission to first decision
28 days

Designed to objectively cover the process of bench to bedside development of cardiovascular drug, device and cell therapy, and to bring you the information you need most in a timely and useful format, Cardiovascular Drugs and Therapy takes a fresh and energetic look at advances in this dynamic field.
Homing in on the most exciting work being done on new therapeutic agents, Cardiovascular Drugs and Therapy focusses on developments in atherosclerosis, hyperlipidemia, diabetes, ischemic syndromes and arrhythmias. The Journal is an authoritative source of current and relevant information that is indispensable for basic and clinical investigators aiming for novel, breakthrough research as well as for cardiologists seeking to best serve their patients.
Providing you with a single, concise reference tool acknowledged to be among the finest in the world, Cardiovascular Drugs and Therapy is listed in Web of Science and PubMed/Medline among other abstracting and indexing services. The regular articles and frequent special topical issues equip you with an up-to-date source defined by the need for accurate information on an ever-evolving field. Cardiovascular Drugs and Therapy is a careful and accurate guide through the maze of new products and therapies which furnishes you with the details on cardiovascular pharmacology that you will refer to time and time again.

Editors-in-Chief:
Willem J. Remme, Rhoon, The Netherlands
Founding Editors:
Henry N. Neufeld
Lionel H. Opie
Associate Editors:
Juan J. Badimon, New York, USA
Yochai Birnbaum, Houston, USA
Y. Eugene Chen, Ann Arbor, USA
Kim A. Connelly, Toronto, Canada 
Harry J.G.M. Crijns, Maastricht, The Netherlands
Sean Davidson, London, UK
Michael Farkouh, Toronto, Ontario, Canada
John Horowitz, Adelaide, Australia
Juan Carlos Kaski, London, UK
Masafumi Kitakaze, Osaka, Japan
Wolfgang Koenig, Ulm Germany
Jay Mehta, Little Rock, Arkansas, USA
Bertram Pitt, Ann Arbor, USA
Carol-Ann Remme, Amsterdam, The Netherlands
Robert S. Rosenson, New York, NY, USA
Derek So, Ottawa, Canada
BASIC PHARMACOLOGY

Adolfo Garcia-Ocaña, New York, NY, USA
David Grieve, Belfast, UK
Barbara Huisamen, Tygerberg, South Africa
Qing Jing, Shanghai, China
Thomas Krieg, Cambridge, UK
Wei Kong, Beijing, China
Robert Lasley, Detroit, Michigan, USA
Roberto Latini, Milan, Italy
David J. Lefer, Atlanta, USA
Amanda Lochner, Stellenbosch, South Africa
Gary Lopaschuk, Edmonton, Canada
Hani Sabbah, Detroit, Michigan, USA
Robert Schwinger, Weiden, Germany
Joss du Toit, Southport, Australia
Thomas Unger, Berlin, Germany
Nanping Wang, Beijing, China
Gemma Vilahur, Barcelona, Spain
Huang-Tian Yang, Shanghai, China
Hou-Zao Chen, Beijing, China
Lemin Zheng, Beijing, China
Yi Zhu, Beijing, China

CLINICAL PHARMACOLOGY, DRUGS AND DEVICES

Masanori Asakura, Osaka, Japan
Lina Badimon, Barcelona, Spain
Eric Bruckert, Paris, France
Josep Brugada, Barcelona, Spain
Alberto Corsini, Milan, Italy
Jan Danser, Rotterdam, The Netherlands
Jie Du, Beijing, China
Masatsugu Hori, Osaka, Japan
Yu Huang, Hong Kong, China
John McNeil, Melbourne, Australia
Marco Metra, Brescia, Italy
Sascha N. Goonewardena, Ann Arbor, MI, USA
Thomas Szucs, Zürich, Switzerland
Juan Tamargo, Madrid, Spain
Dimitrios Tziakas, Alexandroupolis, Greece
Rajesh Vedanthan, New York, NY
Adriaan Voors, Groningen, The Netherlands
Aimin Xu, Hong Kong, China
Cheuk-Man Yu, Shatin, Hongkong
Yunzeng Zou, Shanghai, China
Coert J. Zuurbier, Amsterdam, The Netherlands

CLINICAL TRIALS 

Dimitrios Alexopoulos, Athens, Greece
Inder Anand, Minneapolis, Minnesota, USA
Andreas Goette, Magdeburg, Germany
Aldo Maggioni, Milan, Italy
Luis Ruilope, Madrid, Spain
Mandeep Sidhu, Albany, NY
Mark Talan, Baltimore, USA

Editorial Assistant: Noor van Dam, Rhoon, The Netherlands